Tools & Calculators
ICICI Pru Pharma Healthcare Diag Gr
as of 16 Mar 2026, 13:20 PM
Invested Amount
Est. Return
Total Value
rated by Value Research
Your principal will be at Very High Risk
Absolute Returns
CAGR
Company Name | Sector | Instrument | Assets |
|---|---|---|---|
| Sun Pharmaceuticals Industries Ltd | Healthcare | E | 11.21% |
| Cipla Ltd | Healthcare | E | 9.40% |
| Mankind Pharma Ltd | Healthcare | E | 7.64% |
| Dr Reddy's Laboratories Ltd | Healthcare | E | 6.52% |
| Biocon Ltd | Healthcare | E | 6.20% |
| Divi's Laboratories Ltd | Healthcare | E | 5.95% |
| Lupin Ltd | Healthcare | E | 3.99% |
| Aurobindo Pharma Ltd | Healthcare | E | 3.70% |
| Alkem Laboratories Ltd | Healthcare | E | 3.47% |
| Syngene International Ltd | Healthcare | E | 3.16% |
| Cohance Lifesciences Ltd | Healthcare | E | 2.77% |
| Medplus Health Services Ltd | Healthcare | E | 2.54% |
| Alivus Life Sciences Ltd | Healthcare | E | 2.11% |
| Zydus Lifesciences Ltd | Healthcare | E | 2.07% |
| Akums Drugs and Pharmaceuticals Ltd | Healthcare | E | 1.77% |
| J.B. Chemicals & Pharmaceuticals Ltd | Healthcare | E | 1.75% |
| Thyrocare Technologies Ltd | Healthcare | E | 1.75% |
| Alembic Pharmaceuticals Ltd | Healthcare | E | 1.60% |
| Gland Pharma Ltd | Healthcare | E | 1.54% |
| Entero Healthcare Solutions Ltd | Healthcare | E | 1.46% |
| Pfizer Ltd | Healthcare | E | 1.34% |
| Medi Assist Healthcare Services Ltd | Healthcare | E | 1.31% |
| Blue Jet Healthcare Ltd | Healthcare | E | 1.22% |
| Metropolis Healthcare Ltd | Healthcare | E | 1.21% |
| Glenmark Pharmaceuticals Ltd | Healthcare | E | 1.19% |
| Fine Organic Industries Ltd Ordinary Shares | Basic Materials | E | 1.17% |
| Hikal Ltd | Healthcare | E | 1.15% |
| Anthem Biosciences Ltd | Healthcare | E | 1.09% |
| Aarti Drugs Ltd | Healthcare | E | 0.98% |
| Shilpa Medicare Ltd | Healthcare | E | 0.97% |
| Windlas Biotech Ltd | Healthcare | E | 0.95% |
| Sanofi Consumer Healthcare India Ltd | Healthcare | E | 0.88% |
| AstraZeneca Pharma India Ltd | Healthcare | E | 0.76% |
| Senores Pharmaceuticals Ltd | Healthcare | E | 0.71% |
| FDC Ltd | Healthcare | E | 0.63% |
| Laxmi Dental Ltd | Healthcare | E | 0.63% |
| Nephrocare Health Services Ltd | Healthcare | E | 0.48% |
| Sun Pharma Advanced Research Co Ltd | Healthcare | E | 0.45% |
| Rubicon Research Ltd | Healthcare | E | 0.26% |
| Tbill | - | BT | 0.03% |
| Treps | - | CR | 2.18% |
| Net Current Assets | - | C | 0.19% |
| Cash Margin - Derivatives | - | CA | 0.00596% |
| Procter & Gamble Health Ltd | - | E | - |
Equity / Debt / Cash Split
Equity
97.98%
Cash
2.02%
Equity sector allocation
Basic Materials
1.17%
Healthcare
96.81%
Others
2.02%
Asset Management Company

Mirae Asset NYSE FANG+ ETF FoF Reg Gr
Equity
Min. Investment
₹5000
Category Returns
32.61%
54.68%
3Y Returns
+54.68%

DSP Wld Gld Mng Ovrs Eq Omni FoF Gr
Equity
Min. Investment
₹100
Category Returns
32.61%
54.68%
3Y Returns
+54.48%

DSP Wld Gld Mng Ovrs Eq Omni FoF IDCW-R
Equity
Min. Investment
₹100
Category Returns
32.61%
54.68%
3Y Returns
+54.34%
Investment Objective of the Scheme
Key Features of The Fund
5-year return
+16.61%
Fund Manager
Dharmesh Kakkad
Risk Profile
Very High Risk
Expense Ratio
1.86%
Fund Size
₹6801.16 Cr
By signing up I certify terms, conditions & privacy policy